AzTrials
AzTrials

Sedentary BehaviorNCT05281978

One Step at a Time: An Intervention to Reduce Sedentary Behavior Among Working Adults

A study testing Decrease Sedentary Time + Increase MVPA group and Increase MVPA group in people with Sedentary Behavior and Exercise, run by University of Illinois at Urbana-Champaign at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study will test the preliminary efficacy of a novel 12-week social cognitive theory-based intervention that will target reducing daily sitting time and increasing exercise participation among middle-aged working adults. Read more about this study

Who is it for?
Ages 45 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Sedentary Behavior, Exercise, Middle Age
What is being tested?
Decrease Sedentary Time + Increase MVPA group and Increase MVPA group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteUnited States
Study dates
25 Apr 2022to 1 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 45-65 years of age by study start date
  • Hold full-time employment (≥ 30 hours/week) at one or more jobs
  • Hold a sedentary-based job (which also allows for ability to freely move about during the workday)
  • Low active (engage in ≤2 days of 30+ minutes of structured moderate-vigorous intensity exercise/week)
  • Physician's consent to participate in aerobic testing and/or the exercise program (if needed based on Physical Activity Readiness Questionnaire responses)
  • Ambulatory
Show all 10Show fewer
  • Absence of health conditions that may be made worse by exercise
  • Ability to complete all testing assessments in-person
  • Access to a laptop/desktop/phone with Zoom web-conferencing software
  • Fluent in English

Who cannot join

  • Under 45 or over 65 years of age
  • Not holding full-time employment (work < 30 hours/week at one or more jobs)
  • Hold a job(s) which is classified as light, medium, heavy, or very heavy work
  • Hold a sedentary-based job which does not allow for free movement throughout the workday (i.e., bus driver)
  • High active (engage in > 2 days or 30+ minutes of structured moderate-vigorous intensity exercise/week)
  • Non-consent of physician
Show all 10Show fewer
  • Non-ambulatory (i.e., use of walkers, wheelchair, cane, etc.)
  • Presence of health conditions that may be made worse by exercise.
  • Unable to complete assessments in-person
  • No access to laptop/desktop/phone with Zoom software

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Univeristy of Illinois Urbana-Champaign

    Urbana, Illinois, 61801

Other trials in United States

About this study

Official title: One Step at a Time: Testing the Efficacy of a Novel Social Cognitive Theory-Based Intervention to Reduce Sedentary Behavior Among Working Adults

The proposed study will test the preliminary efficacy of a novel 12-week social cognitive theory-based intervention that will target reducing daily sitting time and increasing exercise participation among middle-aged working adults. This is a population highly susceptible to excessive sedentary time and low levels of exercise engagement. This two-arm randomized controlled trial (RCT) will examine the preliminary efficacy of decreasing sedentary time in addition to increasing moderate-vigorous intensity physical activity (MVPA) engagement, compared to a group which only receives MVPA promotion.

Being tested
Decrease Sedentary Time + Increase MVPA group, Increase MVPA group
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Decrease Sedentary Time + Increase MVPA groupBehavioural

    12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise; personalized step count goals to increase daily volume of physical activity and displacement of sedentary time

  • Increase MVPA groupBehavioural

    12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise

Study groups in NCT05281978
Study groupRoleWhat they receive
Decrease Sedentary Time + Increase MVPAExperimentalParticipants in this group will receive a 12-week, social cognitive theory-based intervention targetting reduction of daily sedentary time. This information will be delivered to them in the form of Zoom workshops, a program workbook, personalized step count goals, and a private social media page. The aim of this component will be to have participants displace their daily sedentary time with light-intensity physical activity, such as casual walking. The second component of this intervention will be increasing participants' weekly MVPA engagement. Participants will participate in 1 live, virtual aerobics-based exercise class per week and complete 2 additional sessions on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).
Receives: Behavioral: Decrease Sedentary Time + Increase MVPA group
Increase MVPA onlyActive comparatorParticipants in this group will only receive the MVPA-promoting component (which will be the same delivery as the intervention group). Participants in this arm will participate in 1 live, virtual aerobics-based exercise class per week (held separately from the intervention group) and will complete 2 additional exercise classes on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).
Receives: Behavioral: Increase MVPA group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in average daily step counts

    Participants will wear a hip-based pedometer for 7 days at baseline and 12 weeks

    Measured: Baseline,12 weeks

  2. Changes in average daily sedentary time

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent sedentary.

    Measured: Baseline,12 weeks

  3. Changes in average daily light-intensity physical activity

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent engaged in light-intensity physical activity.

    Measured: Baseline,12 weeks

  4. Changes in average daily moderate-vigorous intensity physical activity

    Participants will wear a hip-based accelerometer for 7 days at baseline and 12 weeks to measure their daily time spent engaged in moderate-vigorous intensity physical activity.

    Measured: Baseline, 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2022
  2. Study start25 Apr 2022
  3. Primary completion1 Aug 2023
  4. Study completion1 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05281978
Sponsor's protocol ID
22651
Status last verified
Aug 2023
First submitted
7 Mar 2022
Last updated
28 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Decrease Sedentary Time + Increase MVPA group and Increase MVPA group in people with Sedentary Behavior and Exercise, run by University of Illinois at Urbana-Champaign at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in average daily step counts (time frame: Baseline,12 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in